Author

Lucien Courtois

Hôpital Necker-Enfants MaladesORCID 0000-0002-4156-3008Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Aurélie Cabannes‐HamyiD· 1 shared Camille Gillet· 1 shared Guillaume P. AndrieuiD· 1 shared Ismail Ceylan· 1 shared Ludovic LhermitteiD· 1 shared Mélanie Féroul· 1 shared Mélodie QueriiD· 1 shared Mickael Bonnet· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aurélie Cabannes‐HamyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMar 11, 2025

Harnessing ALDH1A2 vulnerability in T-cell acute lymphoblastic leukemia

Guillaume P. Andrieu, Lucien Courtois, Mickael Bonnet…·Vahid Asnafi

This study identifies ALDH1A2 as a therapeutic target in T-ALL, showing its essential role in leukemic cell survival and demonstrating potent anti-leukemic activity with Dimate inhibition.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky